• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同水化方法预防择期经皮冠状动脉介入治疗患者对比剂肾病的回顾性研究。

Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.

机构信息

Department of Cardiology, the Second Hospital of Hebei Medical University and the Institute of Cardiocerebrovascular Disease of Hebei Province, Shijiazhuang, 050000, China.

出版信息

BMC Cardiovasc Disord. 2023 Jun 24;23(1):323. doi: 10.1186/s12872-023-03358-w.

DOI:10.1186/s12872-023-03358-w
PMID:37355592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10290803/
Abstract

BACKGROUND

Hydration is currently the main measure to prevent contrast-induced nephropathy (CIN). We aimed to compare the preventive effect of preprocedure and postprocedure hydration on CIN in patients with coronary heart disease undergoing elective percutaneous coronary intervention (PCI).

METHODS

A retrospective study included 198 cases of postprocedure hydration and 396 cases of preprocedure hydration using propensity score matching. The incidence of CIN 48 h after PCI and adverse events within 30 days after contrast media exposure were compared between the two groups. Logistic regression analysis was used to analyse the risk factors for CIN.

RESULTS

The incidence of CIN in the postprocedure hydration group was 3.54%, while that in the preprocedure hydration group was 4.8%. There was no significant difference between the two groups (p = 0.478). Multivariate logistic regression analysis showed that diabetes mellitus, baseline BNP and cystatin C levels, and contrast agent dosage were independent risk factors for CIN. There was no significant difference in the incidence of major adverse events between the two groups (3.03% vs. 2.02%, p = 0.830).

CONCLUSIONS

Postprocedure hydration is equally effective compared to preoperative hydration in the prevention of CIN in patients with coronary heart disease undergoing elective PCI.

摘要

背景

水化目前是预防对比剂肾病(CIN)的主要措施。我们旨在比较择期经皮冠状动脉介入治疗(PCI)前和后水化对冠心病患者 CIN 的预防效果。

方法

回顾性研究纳入了 198 例术后水化和 396 例术前水化的患者,采用倾向评分匹配。比较两组患者 PCI 后 48 小时 CIN 的发生率和造影剂暴露后 30 天内的不良事件。采用 logistic 回归分析 CIN 的危险因素。

结果

术后水化组 CIN 的发生率为 3.54%,而术前水化组为 4.8%。两组间无显著差异(p = 0.478)。多因素 logistic 回归分析显示,糖尿病、基线 BNP 和胱抑素 C 水平以及造影剂剂量是 CIN 的独立危险因素。两组间主要不良事件的发生率无显著差异(3.03%比 2.02%,p = 0.830)。

结论

对于择期 PCI 的冠心病患者,术后水化与术前水化预防 CIN 的效果相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4923/10290803/82e61ce2944b/12872_2023_3358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4923/10290803/af96f857b79f/12872_2023_3358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4923/10290803/82e61ce2944b/12872_2023_3358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4923/10290803/af96f857b79f/12872_2023_3358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4923/10290803/82e61ce2944b/12872_2023_3358_Fig2_HTML.jpg

相似文献

1
Different hydration methods for the prevention of contrast-induced nephropathy in patients with elective percutaneous coronary intervention: a retrospective study.不同水化方法预防择期经皮冠状动脉介入治疗患者对比剂肾病的回顾性研究。
BMC Cardiovasc Disord. 2023 Jun 24;23(1):323. doi: 10.1186/s12872-023-03358-w.
2
Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.前列地尔预防经皮冠状动脉介入治疗患者造影剂肾病的疗效:一项多中心前瞻性随机对照试验。
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):742-750. doi: 10.1002/ccd.27353. Epub 2017 Oct 10.
3
The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.普罗布考联合水化预防冠心病经皮冠状动脉介入治疗患者对比剂肾病的疗效:一项多中心、前瞻性、随机对照研究。
Int Urol Nephrol. 2018 Jan;50(1):105-112. doi: 10.1007/s11255-017-1718-4. Epub 2017 Oct 25.
4
Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.别嘌醇联合水化预防高尿酸血症患者行经皮冠状动脉介入治疗后对比剂肾病的随机对照试验:CONSORT 报告。
Medicine (Baltimore). 2022 Jan 28;101(4):e28683. doi: 10.1097/MD.0000000000028683.
5
Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.急性心肌梗死患者行紧急经皮冠状动脉介入治疗后应用脉搏指示连续心排血量监测指导的强化补液对预防对比剂肾病的影响。
Am J Cardiol. 2023 May 15;195:77-82. doi: 10.1016/j.amjcard.2023.03.001. Epub 2023 Apr 3.
6
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.经皮冠状动脉介入治疗慢性完全闭塞病变与非闭塞性冠状动脉疾病对比所致对比剂肾病。
Am J Cardiol. 2018 Dec 1;122(11):1837-1842. doi: 10.1016/j.amjcard.2018.08.022. Epub 2018 Sep 8.
7
Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention.糖化血红蛋白水平与接受冠状动脉造影/经皮冠状动脉介入治疗的糖尿病患者对比剂肾病风险的关系。
BMC Nephrol. 2021 Jun 2;22(1):206. doi: 10.1186/s12882-021-02405-y.
8
A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.用于预测糖尿病患者冠状动脉造影后对比剂诱导肾病的简单风险评分模型。
Clin Exp Nephrol. 2019 Jul;23(7):969-981. doi: 10.1007/s10157-019-01739-0. Epub 2019 May 2.
9
Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.选择性经皮冠状动脉介入治疗期间最小造影剂用量对稳定型冠状动脉疾病患者预防造影剂肾病的影响。
Cardiovasc Interv Ther. 2016 Jan;31(1):13-20. doi: 10.1007/s12928-015-0337-1. Epub 2015 May 23.
10
A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.一种新型的糖尿病患者经皮冠状动脉介入治疗后对比剂诱导肾病风险评估模型。
Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):305-314. doi: 10.1111/bcpt.13501. Epub 2020 Oct 15.

引用本文的文献

1
Simplified rapid hydration and contrast-associated acute kidney injury among CKD patients stratified by Mehran score: sub-analysis from the TIME Trial.根据梅兰评分分层的慢性肾脏病患者简化快速水化与造影剂相关急性肾损伤:TIME试验的亚组分析
Perioper Med (Lond). 2024 Oct 14;13(1):103. doi: 10.1186/s13741-024-00462-z.
2
Evaluation of Emerging Predictors for Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的高危患者中对比剂肾病新兴预测指标的评估
Cureus. 2024 Jul 11;16(7):e64363. doi: 10.7759/cureus.64363. eCollection 2024 Jul.

本文引用的文献

1
Systematic review and meta-analysis of prophylaxis use with intravenous contrast exposure to prevent contrast-induced nephropathy.系统评价和荟萃分析:静脉对比剂暴露后预防对比剂肾病的预防用药。
Eur J Radiol. 2022 Aug;153:110368. doi: 10.1016/j.ejrad.2022.110368. Epub 2022 May 23.
2
Predictive value of creatine kinase MB for contrast-induced acute kidney injury among myocardial infarction patients.肌酸激酶同工酶 MB 对心肌梗死患者对比剂诱导急性肾损伤的预测价值。
BMC Cardiovasc Disord. 2021 Jul 13;21(1):337. doi: 10.1186/s12872-021-02155-7.
3
Advances in the pathogenesis and prevention of contrast-induced nephropathy.
对比剂诱导肾病发病机制和预防的研究进展。
Life Sci. 2020 Oct 15;259:118379. doi: 10.1016/j.lfs.2020.118379. Epub 2020 Sep 3.
4
Standard vs. double dose of intravenous nicorandil in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing elective coronary procedures.标准剂量与双倍剂量静脉注射尼可地尔预防接受择期冠状动脉手术的冠心病患者造影剂肾病的比较
Coron Artery Dis. 2021 May 1;32(3):256-257. doi: 10.1097/MCA.0000000000000927.
5
Contrast-induced acute kidney injury.对比剂诱导的急性肾损伤
Cardiovasc Interv Ther. 2020 Jul;35(3):209-217. doi: 10.1007/s12928-020-00660-8. Epub 2020 Apr 6.
6
Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis.水化策略预防对比剂急性肾损伤:系统评价和贝叶斯网状 Meta 分析。
J Interv Cardiol. 2020 Feb 11;2020:7292675. doi: 10.1155/2020/7292675. eCollection 2020.
7
Value of C-Reactive Protein/Albumin Ratio in Predicting the Development of Contrast-Induced Nephropathy in Patients With Non-ST Elevation Myocardial Infarction.C 反应蛋白/白蛋白比值在预测非 ST 段抬高型心肌梗死患者对比剂肾病发展中的价值。
Angiology. 2020 Apr;71(4):366-371. doi: 10.1177/0003319719898057. Epub 2020 Jan 31.
8
Effect of acute kidney injury on long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent primary percutaneous coronary intervention in a high-volume tertiary center.在高容量三级中心接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死合并心原性休克患者中,急性肾损伤对长期死亡率的影响。
Turk Kardiyol Dern Ars. 2020 Jan;48(1):1-9. doi: 10.5543/tkda.2019.84401.
9
Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.远程缺血预处理可降低行冠状动脉造影/介入治疗患者对比剂肾病的发生率:系统评价和随机对照试验的荟萃分析。
Catheter Cardiovasc Interv. 2020 Nov;96(6):1200-1212. doi: 10.1002/ccd.28709. Epub 2020 Jan 8.
10
ACR Manual on Contrast Media: 2018 Updates.《美国放射学会对比剂手册:2018年更新版》
Radiol Technol. 2019 Sep;91(1):97-100.